Monument Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Monument Capital Management's GSK Position: Q3 2026 in Review
Monument Capital Management reduced its GSK (GSK) stake by 1.4% in Q3 2026, selling an estimated $3.78K and leaving 5,183 shares worth $250K. The position accounts for 0.05% of the portfolio, ranked #228.
Monument Capital Management first reported a position in GSK in Q3 2025 and has held it in 5 quarters since. The position peaked at $290K in Q1 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Monument Capital Management held 5,183 shares of GSK worth $250K as of Q3 2026.
- Monument Capital Management sold 74 GSK shares in Q3 2026, an estimated $3.78K.
- GSK made up 0.05% of Monument Capital Management's portfolio in Q3 2026, its #228 holding.
- Monument Capital Management first reported a position in GSK in Q3 2025 and has held it in 5 quarters since.
- Monument Capital Management's GSK position peaked at $290K in Q1 2026.
- 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Monument Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.